Atea Pharmaceuticals Inc
NASDAQ:AVIR

Watchlist Manager
Atea Pharmaceuticals Inc Logo
Atea Pharmaceuticals Inc
NASDAQ:AVIR
Watchlist
Price: 3.65 USD 0.83%
Market Cap: 285.2m USD

Wall Street
Price Targets

AVIR Price Targets Summary
Atea Pharmaceuticals Inc

Wall Street analysts forecast AVIR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AVIR is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Lowest
Price Target
6.06 USD
66% Upside
Average
Price Target
6.12 USD
68% Upside
Highest
Price Target
6.3 USD
73% Upside
Atea Pharmaceuticals Inc Competitors:
Price Targets
600993
Mayinglong Pharmaceutical Group Co Ltd
36% Upside
APLLTD
Alembic Pharmaceuticals Ltd
26% Upside
ZYDUSLIFE
Zydus Lifesciences Ltd
14% Upside
HITI
High Tide Inc
90% Upside
MRK
Merck & Co Inc
3% Upside
NEU
Neuren Pharmaceuticals Ltd
33% Upside

Revenue
Forecast

Revenue Estimate
Atea Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Atea Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-29%
Average Miss

Net Income
Forecast

Net Income Estimate
Atea Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AVIR's stock price target?
Price Target
6.12 USD

According to Wall Street analysts, the average 1-year price target for AVIR is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Back to Top